IMI 1 GetReal closing meeting:
‘Delivering tools for real-world evidence development’

24 November, 2016, Brussels

Royal Flemish Academy of Belgium for Science and the Arts

GetReal aims to show how robust new methods of RWE collection and synthesis could be developed and considered for adoption earlier in pharmaceutical R&D and the healthcare decision making process. This will require companies, healthcare decision makers and other stakeholders to work together to generate a consensus on best practice in the use of RWE in regulatory and reimbursement decision-making.

Alternative evidence generating strategies will deliver more focused research in pharmaceutical R&D, and allow healthcare decision makers to be more certain when providing patients with access to new treatments.

This closing meeting will provide an update on the status of the project and what has been delivered.

Agenda

November 24th 2016 Royal Flemish Academy of Belgium for Science and the Arts, Brussels

9:30 – 10:30 Coffee and registration
10:30 – 10:35 Welcome by Rick Grobbee (UMCU) and Elaine Irving (GSK)
10:35 – 10:45 Real-world data and the IMI GetReal project

  • Elaine Irving, GSK
  • Rick Grobbee, UMCU
10:45 – 12:25 Insights from GetReal: what has our collaboration delivered?

WP1: Working with stakeholders to explore alternative evidence generation: What have we learnt?

  • Pall Jonsson, NICE
  • Rob Thwaites, Takeda

WP2:

  • Chris Chinn, Sanofi
  • Lucien Abenhaim, LASER Analytica

WP3:

  • Iris Goetz, Eli Lilly
  • Mira Zuidgeest, UMCU

WP4: Evidence Synthesis and Predictive Modelling of Relative Effectiveness – Paving the Way to Best Practice

  • Chrissie Fletcher, Amgen
  • Matthias Egger, University of Bern
12:25 – 12:30 Intro to demos of GetReal tools

  • Elaine Irving, GSK
  • Pieter Stolk, UMCU
12:30 – 14:00 Lunch and demos/try-out of GetReal tools and outputs

  • WP1: RWE Navigator
  • WP2: Toolbox
  • WP3: PragMagic tool and the JCE paper series
  • WP4: ADDIS and high level summaries of research as applied in a series of case studies
  • WP5: GetReal online course ‘Real-world evidence in medicine development’
14:00 – 15:15 Panel discussion ‘Real-world data and drug development: how has GetReal helped?’

  • Chris Chinn (Sanofi)
  • Antonio Ciaglia (IAPO)
  • Rick Grobbee (UMCU)
  • Duane Schulthess (Vital Transformation) – moderator
15:15 – 15:35 Coffee Break
15:35 – 16:50 Panel discussion ‘Getting real about the future of real-world data research’

  • Francesca Cerreta (EMA)
  • Stefan Lange (Iqwig)
  • Sarah Garner (NICE)
  • Duane Schulthess (Vital Transformation) – moderator
16:50 – 17:00 Wrap up

  • Elaine Irving, GSK
  • Rick Grobbee, UMCU

Supported by

2018-03-08T12:57:30+00:00